Noah Labs
ActiveVoice-based heart failure monitoring.
What it does
Noah Labs pioneers the first voice-based biomarker for heart failure. Their AI detects decompensation 2 weeks earlier than current monitoring, enabling timely intervention, fewer hospitalizations, and lower costs. Validated in >1K patients and 5 clinical trials at Mayo Clinic and Charité Berlin, their solution is universal, cost-effective, and requires no additional hardware.
Its site says now · captured 2026-08-23
Noah Labs
A breakthrough for heart failure: Noah Labs Ark is a Class IIa Medical Device Software with AI-driven detection of early cardiac decompensation through voice.